Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft

By Kelner M.J.   McMorris T.C.   Estes L.   Samson K.M.   Bagnell R.D.   Taetle R.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 908-913

Elsevier

Access to resources Recommend Favorite

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model

By Hammond L.A.   Hilsenbeck S.G.   Eckhardt S.G.   Marty J.   Mangold G.   MacDonald J.R.   Rowinsky E.K.   Von Hoff D.D.   Weitman S.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2430-2436

Elsevier

Access to resources Recommend Favorite

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft

By Bigioni M.  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 621-629

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

By Fujimoto-Ouchi Kaori   Sekiguchi Fumiko   Yasuno Hideyuki   Moriya Yoichiro   Mori Kazushige   Tanaka Yutaka  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 795-805

Springer Publishing Company

Access to resources Recommend Favorite

Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model

By Uchida N.   Takeda Y.   Hojo K.   Maekawa R.   Sugita K.   Yoshioka T.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1796-1801

Elsevier

Access to resources Recommend Favorite